读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
百济神州:港股公告:2024年度报告 下载公告
公告日期:2025-04-29

Cancer has no borders. Neither do we.

年度報告2024

?2024

2 4 8 43 129 130 153 162 229 259 264 349 355

?

2024

Olivier Brandicourt

Margaret Han DuganMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. SandersShalini Sharp

Shalini Sharp

Olivier Brandicourt

Corazon (Corsee) D. SandersAnthony C. Hooper

Margaret Han DuganRanjeev Krishana

Anthony C. Hooper

Michael GollerAlessandro RivaShalini Sharp

Alessandro RivaMargaret Han DuganMichael GollerCorazon (Corsee) D. Sanders

* 2024122Thomas MalleyMalley

MalleyMalley

20241025Donald W. Glazer

1. 2024123

2. 2024927

3. 2024927202531

4. 202531

5. 2025116

6. 2024319

?2024

Anthony C. HooperOlivier Brandicourt

Margaret Han DuganRanjeev KrishanaCorazon (Corsee) D. Sanders

(FCG, HKFCG)Vistra Corporate Services (HK) Limited

Ernst & Young LLP

The offices of Mourant Governance Services (Cayman) Limited94 Solaris AvenueCamana BayGrand Cayman KY1-1108Cayman Islands

Mourant Ozannes

171712-1716

Mourant Governance Services (Cayman) Limited94 Solaris Avenue, Camana BayGrand Cayman KY1-1108Cayman Islands

06160

www.beigene.com

?2024

??????

?2024

????????????

?

2024

???????? ADS

???

?2024

?2024

202438146

BTK

?

sonrotoclaxBCL2BTK-CDAC?

BTKALPINE?

(R/R)(CLL)?

BTK

?

BTKCLL(MCL)(WM)(MZL)(FL)CLL

?

R/R CLL?20242670SonrotoclaxBCL2sonrotoclax1,800Sonrotoclax

??

sonrotoclaxCLL3CELESTIALBTK-CDACBTKBTK

500BTK2024(ASH)20253

CLL120CLL

?2024

75%(CRO)

Project Optimus

(IRA)

3,700CRO

(PoC)202413(NME)618PoCCDK4B7H4(ADC)(GI)KRAS(MoA)EGFR-CDAC

PRMT5MAT2ACDK2B7H3 ADCCEA-ADCFGFR2b ADCEGFRxMETIRAK4 CDAC201011,000

?2024

20242025

()NASDAQ: ONC;HK: 06160; SSE: 688235

BeiGene (Hong Kong) Co.,

Limited()()()(

)

(

)

BeiGene UK, Ltd.()

()BeiGene Switzerland GmbH

?2024

3,700CROCRO

1,10015MoACDACADC

CDAC

??

?

357,100

??

sonrotoclaxBTK-CDACCLLB

BTK-CDAC

?

sonrotoclaxCLL

CLL

?

2024

PD-1

PD-1

?

???

2024123126202373%20252024GAAPGAAP2024

?

2024

2025227

?

BTK73?

PD-145

?

PARP

?

RANK?

CD19CD3T(BiTE)??

IL-6EUSA Pharma?

GD2EUSA Pharma?

VEGF?

(GnRH)?

BRAF

?

MEK

?

VEGFR

?

mTOR

?

ALK

1.

?2024

ALK=BRAF=BMEK=(MAPK)

(ERK)mTOR=VEGFR=

?

2024BTK1002028BTK

?

20232024??

BTKBTKBTK

?

B

?

BTKBTK

??

5CLL/SLLWMR/R MCLR/R MZLR/R FL70?201911(FDA)MCLWM

CD20R/R MZL202313?

CLLSLL

?

17p/TP53R/R CLL/SLL(PFS)BTK20243?

FDAR/R FL

?2024

?ECWMR/R MZLCLL202311EC

?

R/R FL

?

BTK

?NMPACLLSLLWMR/R CLL/SLLTN & R/R WMMCL

?NHSANRDL

?202412WMCLL/SLL?

2024PD-1/PD-L14502024PD-1/L1

20255002028??

1(PD-1)IgG4Fcγ(FcγR)FcγRT?

? IIIII(NSCLC)?? PD-L1

?2024

? NSCLC? (EGFR)(ALK)

NSCLC? NSCLC? (ESCC)? ESCC? (NPC)? (HCC)?? (cHL)? 12

PD-L1(UC)? (MSI-H)

(dMMR)

2020

?cHLUCNRDL2021NSCLCNSCLCHCCNRDL2022NSCLCMSI-H

ESCCNPCNRDL2023PD-L1

ESCCNRDL

?2024

EC

?

? PD-L1TAP)>5%ESCC? ESCC? PD-L1≥50%EGFRALK

NSCLC??? PD L1 TAP>5%HER-2G/GEJFDA

?

PD-(L)1ESCCPD-L1≥1HER2G/GEJ

?

ESCC(BLA)?ESCC(J-NDA)(PMDA)?

?2024

?

?XGEVA

?denosumabRANK(RANKL)

(MM)(SRE)(GCTB)

?

?20195GCTB202011SRE20207

?

202012

?

GCTB202320241SRE

?

?BLINCYTO

?

blinatumomabCD-19CD3T

T(BiTE)60(ALL)

?202012R/R ALL20224R/RBALL20218

?

?

?KYPROLIS

?carfilzomib60R/R MM

?20217R/R MM20221??

20233

(BMS)20252?

?REVLIMID

??

?VIDAZA

?

DNA

EUSA Pharma

?2024

?

?SYLVANT

?siltuximab-6(IL-6)(HIV)-8(HHV-8)Castleman(iMCD)

?202112HIVHHV-8Castleman(MCD)iMCD20241

?

??

QARZIBA

?

βdinutuximab betaGD2NMPA

R/R202112

?

?

(BAT1706)

???

NSCLC?202111NMPA2021NSCLC

?

?

?

??

20236NMPA2023NRDL?

20239NMPA2024NRDL

?2024

2024123160

(Medicare)(Medicaid)

myBeiGene(co-pay)

????

1495%

20172022

?2024

202411202511?

?

?

HCC2023122024NRDL

?

(ES-SCLC)202462024

?

202442024NRDL

?

ESCC202352023NRDL

?EGFRALK

NSCLCEGFRALK

NSCLC2021122023NRDL

?

MSI-HdMMR202232023NRDL

?

ESCC202242023NRDL

?

NPC202262023

1 PD-L1

202322023NRDL

?2024

?

EGFRALKNSCLC202162021NRDL

?

202162021NRDL

?

NSCLC202112021NRDL

?PD-L112

(UC)202042020NRDL

?

2cHL2019122020NRDL?

?

?

2(FL)202452024NRDL

?CLLSLL202342023NRDL

?WM202342023NRDL

?

MCL202062020NRDL

2 CLL/SLLCLL/SLL

202062020NRDL3 WMWM

2021620212023

?2024

?

?

?202392024NRDL

?202362023NRDL?

?202410

?

202172023NRDL2018

4+71120182019

(RLD)

?2024

2025227

BTK114US, EU

HER2

203 HER2+ 2L BTC (CN)

PD1

312 1L ES-SCLC (EU)

NSCLC (EU)

306 1L ESCC (US, JP)302 2L ESCC (JP)302 2L ESCC (EU)309 1L NPC (EU)

PD1

310 1L UBC314 R/R cHL

PARP

302 2L MTx gBRCAm PSOC

TIGIT

302 1L NSCLC PDL1

HER2

301 1L HER2+ GEA

BTK

306 TN MCL308 R/R MZL, R/R FL309 pMN

Tarlatamab

DLL3 x CD3

20210004 2L SCLC20200041 1L ES-SCLC20230016 LS-SCLC

SonrotoclaxBCL2

301 TN CLL302 R/R MCL

?

CD3 x CD19

20190359R/R BP-ALL

Tarlatamab

DLL3 x CD3

20230273 3L SCLC

BTK

215 B218 CD79B R/R DLBCL

BGB-16673BTK CDAC

101 R/R CLL102 R/R CLL

BGB-A445OX40

201 UC

IO

LC-201 1L NSCLCLC-202NSCLCHNSCC-201 1L HNSCC

LBL-007

LAG3

201 MSS-CRC202 1L ESCC

SonrotoclaxBCL2

201 R/R MCL202 R/R CLL203 R/R WM204 TN CLL/SLL

BTK CDAC

BGB-R046

IL-15BGB-B2033

GPC3 x4-1BB

BGB-B3227

MUC1 x CD16ABGB-15025

HPK1BGB-26808

HPK1

BGB-A3055

CCR8BGB-24714

SMAC

PD1

BGB-B455

?

CLDN6 xCD3

BGB-30813

DGK

Xaluritamig

20180146 mCRPC

STEAP1 xCD3 XmAb

?BGB-21447101 B

BCL2

BGB-16673

101 B102 B104 B

BGB-43395CDK4

101/102 BC &

BG-89894

MAT2A

BGB-45035IRAK4 CDAC

BG-68501

CDK2

101 BC &

BGB-53038

KRAS

BG-C9074

B7H4 ADC

EGFR CDACBG-60366

BG-C354B7H3 ADC

BG-C477CEA ADC

BG-C137FGFR2b ADC

BG-58067

MTAPRMT5

EGFR x

METBG-T187

BCL2Sonrotoclax101 B102 B103 AML/MD S105 MM t (11;14)

?2024

2025227

Tarlatamab ^SCLC3Xaluritamig1Zymeworks

? + + GEA3?BTC2SpringWorksBGB-3245

SEA-CD70MDSAML1BG-C9074/DB1312BCECOCCCA

NSCLC

1aCDK21MAT2A1

^ BiTE

?

;?ZW25;

SpringWorksMapKureAML=BC=BTC=GEA=MDS=NSCLC=SCLC=EC=OC=CCA=

(SEC)

?2024

?

BTK

?

B?

24BTK

??BTKR/R CLLBTK

?

30357,100

?70180,0003SEQUOIA15

?

(TN)CLLSLLPFS54PFS80%2024ASHTN CLLBOVen596%92%(uMRD)uMRDMRD34

2024ASH

?

? MANGROVE

MCL(NCT04002297)? MAHOGANY

(FL)(NCT05100862)

?

MCLMZLCLL/SLLsonrotoclaxCLL/SLL3sonrotoclaxBTK-CDAC(BGB-16673)

?

?2024

Sonrotoclax (BGB-11417)Bcl-2SonrotoclaxBCL2

2024121,800SonrotoclaxR/R MCL(NCT05471843)R/R CLL/SLL(NCT05479994)2R/R WM2(NCT05952037)3CELESTIAL-TN CLL(NCT06073821)TN-CLLsonrotoclax?

2025TN-CLL2(NCT06637501)sonrotoclax

??TN-CLL/SLL1(NCT04277637)2024ASHSonrotoclax?

TN CLL/SLL

MRD(TLS)BCL2sonrotoclaxR/R MCLR/R CLLBGB-16673BTKCDACBGB-16673BTK(CDAC)

BTKBTKBTKBGB-16673BTK500FDABGB-16673BTKBCL2R/R CLL/SLLR/R MCL1/2CaDAnCe-101 CLL(NCT05006716)2024ASHBGB-16673BTK

BTKBTKBCL2CLL/SLLWM

?2024

? CLL/SLLBGB-16673200 mgORR94%2

(CR/CRi)57%≥3TEAE≥3TEAE≥10%(20%)(10%)885? BGB-16673(DCR)93%

(VGPR)26%45%≥ 3TEAE≥ 3TEAE≥ 20%

R/R CLL220253

BGB-16673BTKR/R MCLR/R CLL/SLL3

?

PD-1

?

PD-1

?

14103423?

?

cHLNCT044863913?

?

3(NCT03967977)?

?

MSI-H/dMMR2(NCT03736889)20241235

?

14,0004,700820243

?ESCC(NCT03957590)

?

2024

(BGB-A1217)TIGIT(BGB-A1217)TIGITIgG13AdvanTIG-302(NCT04746924)

?

NSCLC2024122,000AdvanTIG-302BG-60366EGFRCDACBG-60366EGFRCDACEGFR1

(NCT06685718)BG-89894 (SYH2039)MAT2ABG-89894(SYH2039)MAT2A1

(NCT06568614)202412BGB-58067MTAPRMT5BGB-58067MTAPRMT5MTAP

1(NCT06568614)BG-T187EGFRxMETBG-T187EGFRxMET1(NCT06598800)BGB-26808HPK-1BGB-26808HPK-1BGB-15025

1(NCT05981703)BGB-C354B7H3 ADCBGB-C354B7H3

1(NCT06422520)

?

2024

HER2ZIIHERA

?

HER2Zymeworks Inc.Jazz Pharmaceuticals plc

(NCT05152147)

?

HER2HER2(BTC)2bJazzBTC(NCT06282575)20245BTCBLANMPA202412(ODD)20241120FDAJazz ZIIHERA

?

HER220247JazzBTCBG-C137FGFR2b ADCBG-C137FGFR2b1(NCT06625593)BGB-53038KRASBGB-53038KRASKRAS

1(NCT06585488)BGB-B2033GPC3x4-1BBBGB-B2033GPC3x4-1BB

1(NCT06427941)BGB-B3227MUC1xCD16ABGB-B3227MUC1xCD16A

1(NCT06540066)BG-C477CEA ADCBG-C477CEA1

(NCT06596473)

?2024

BGB-43395CDK4BGB-43395CDK4(HR+)

2(HER2-)(BC)1(NCT06120283)BG-68501CDK2BG-68501CDK2BGB-43395CDK4HR+HER21(NCT06257264)

BG-68501BG-C9074B7H4 ADCBG-C9074B7H4

1(NCT06233942)BG-C9074BGB-21447Bcl-2BGB-21447Bcl-21(NCT05828589)sonrotoclaxBGB-21447

sonrotoclaxBGB-21447BGB-45035IRAK4CDACBGB-45035IRAK4(CDAC)1

(NCT06342713)

?2024

CMOCMO(cGMP)cGMP

?2024

20247

I95100

8,000

5.26

2024202520252

2025

15.8

2019920201224,00020248x5,00064,000

?20244ADC2x5002x50065,000

?2024

CMOCRO

FDA20251API

EMABMS

CMO

?2024

CROAPI

20191031BeiGene Switzerland GmbH

202012

???

?

12.5

?2024

AMG510

AMG 51020232(i)2023112023831

AMG 510(ii)AMG 510

2019103120201215,895,001206,635,01320.5%27.8

13.45174.85

?2024

(i)(a)(b)(c)(ii)5%(iii)(a)(b)

(i)(ii)125%

20.6%

20203172020924

20.6%

20.4%(i)

(ii)202012120231212023130

Anthony C. HooperHooper20222025

?2024

202521463152870

?2024

2025214

?

2034203420342037203720372037203720392043204320432034

2037

203420372037203420372037

?

2033

20332033203320332033

2033203320332033203320332033?

2031

?2024

203820382038Sonrotoclax2039

20392039

1. patent term extension, PTEsupplemental

protection certificate, SPC2.

20363.

4. 2038

5. 2038

2025214

?

2029?

20252025214

?

2034

?2024

??

?Jaypirca?

???

?

?

?

BAVENCIO

?

LIBTAYO

?JEMPERLI

?

LOQTORZI

?PD-1/L1PD-1xCTLA-4

BCL-2sonrotoclaxBTKBGB-16673CDAC

?

2024

SonrotoclaxBGB-16673Loxo

Nurix TherapeuticsNX-5948

ABBV-101

ADC

?2024

?2024

2017201910

201920202021

???

?2024

?2024

MedicareMedicaid

FDA

?2024

?????

2020ABRAXANE

?ABRAXANE

?2020

??

?2024

???

?

?2024

????????

?2024

CROGMP

?2024

?2024

NMPA

20247FDA

FDAFDA

2020NMPAABRAXANE

?

?2024

(Federal Anti-Kickback Statute)(Federal False Claims Act)FCA

?2024

MedicareMedicaid

340BFSS

Tricare

CMS

340B340B

?2024

340B340BDFSSTricare

FCA

340B340B340B340B

FDA

FDAFDA

?2024

NMPAEMA

FDANMPAEMA

????????

?

2024

???2022

?

?2022FDA

?

(ESCC)BLA2024FDA

?(ESCC)

FDAFDA

2025314

?2024

FDA

FDAFDAIND(i)GCP

(ii) FDAFDA(i)(ii)(iii)FDA

FDAFDAFDAFDA

FDA

?2024

FDANMPAEMAGMP

2020NMPAABRAXANE

?

FDANMPAEMAREMS

FDANMPAEMA

?

2024

FDANMPAEMA

??? FDANMPAEMA??FDANMPAEMAFDANMPAEMAFDANMPAEMA

?2024

???????

FDAFDA

AE

SAE

SECAESAEIRAE

?2024

?????

?

??

?2024

Creating and Restoring Equal Access toEquivalent Samples ActCREATES

FDA

2003(Medicare Prescription Drug, Improvement, andModernization Act of 2003)20241FDA

FDA

?2024

2024123186

2025GAAP

12.5

202420232022123111215202420232022

6920

?2024

201792019

?2024

?2024

20233

(La Jolla)Silvergate Bank(Santa Clara)Silicon Valley BankSVBFDIC

2024123110

?2024

20241231261,130

20241231

?2024

?2024

FDAANDAOB

ANDA202438BeiGene USA, Inc.BeiGene Switzerland GmbHSandoz Inc.

MSN Pharmaceuticals, Inc.MSN Laboratories Private Ltd.MSN

MSNFDA

?

(ANDA)OBANDA

2023613Pharmacyclics LLCPharmacyclics

?

2023613

?2024

20249BTK

BGB-16637

?

2024

???Catalent Pharma Solutions, LLCCatalent

?

???? FDA

?2024

????20203NMPAABRAXANE

?

?2024

2019

???2021(Novartis Pharma AG)

PD-1

?

20239202112

TIGIT20237202412

2A (MAT2A)

?2024

??

????

?2024

???

?2024

KRAS G12CLUMAKRAS(sotorasib)(AMG 510)20232

(i)2023112023831AMG 510(ii)AMG 51020202022HGRACHGRAC

HGRAC

?2024

202410,50011,0005%

11,000

?2024

Aaron Rosenberg

?2024

20229

?

2024

2021

2021

?2024

FDANMPAEMAFDANMPAEMAFDANMPAEMA

?2024

1934

2002

????

?2024

???

?

2020206,635,013

20.5%

(i)(ii)(iii)

?2024

?2024

?2024

?2024

?

2024

(Artificial Intelligence Act)FDA

?

2024

(Health Insurance Portability and Accountability Act)(Consumer Privacy Act)PIPL

14117EO 14117

20254

FDA

?2024

PIPL

PIPL

?2024

20249

?2024

2022920243

1001

?2024

20222

202511

?

2024

PIPLPIPL

PIPL5,0005%PIPL

PIPL

?2024

2019

?2024

FDA

FDA

FDA2025314

?2024

?2024

2017LIBORLIBOR

LIBOR2023630LIBORARRC

LIBORAARCSOFRLIBORSOFRLIBORSOFRLIBORSOFRSOFRLIBORSOFR

LIBORLIBOR

?2024

OECD/G20

(BEPS)2020201911

2.02019430

201911201971201911

?2024

?

2024

VIE

20217

20217VIE20232

52023331

?2024

20232

2023331

?2024

Holding Foreign Companies Accountable ActHFCAA

20212021123110-KHFCAA

Ernst &Young LLP20221231

Ernst & Young LLP2022

?2024

20201

?

2024

???

202325

?2024

?2024

20211

10%50%

2024123117

?2024

2016

10%

25%5%BeiGene (Hong Kong) Co., Limited20101122

?2024

(i)(ii)(iii)(iv)

25%

10%20%

10%20%

?

2024

25%

10%

?2024

?2024

?2024

?2024

ONC06160688235

20252141,387,367,7040.0001870,983,67266,998,74413115,055,260

?

2024

202359S-3298,738,765

17,141,156222,835,028

?2024

?2024

?2024

?2024

1933

?2024

?2024

2018

0.2%0.1%

?2024

202521449%

?2024

(1)75%(2)50%

(PFIC)20241231

(Internal Revenue Service)

?2024

F

50%50%10%10%1986(Internal Revenue Code of 1986)

20248206(Swiss Federal Code on Private International Law)161

2025310

?2024

50%

2025

2025310

?2024

35%

15%10%5%

10%10%

35%35%

35%2025310

?

2024

?2024

123120202021202220232024

308,874633,9871,254,6122,189,8523,779,546

–542,296161,309268,92730,695308,8741,176,2831,415,9212,458,7793,810,241238,2171,011,3771,129,4462,078,8593,216,1521,618,1941,438,5881,961,037825,836533,0011,628,5911,457,8162,003,815881,708644,7861,624,9741,457,8162,003,815881,708644,78677%86%80%85%84%-527%-124%-142%-36%-17%

123120202021202220232024

1,390,0054,382,8873,875,0373,185,9842,638,7473,268,7252,241,962665,2512,600–3,885,4916,014,3253,738,5502,393,3011,776,6945,534,7958,535,5256,379,2905,805,2755,920,9101,731,5142,402,9621,995,9352,267,9482,588,6883,803,2816,132,5634,383,3553,537,3273,332,222

(1) 10-K

?2024

(GAAP)GAAPGAAP

GAAPGAAPGAAP

GAAPGAAPGAAPGAAP

GAAPGAAPGAAP

GAAPGAAPGAAPGAAPGAAPGAAP

?2025?

(CLL)BTK

?

BCL2sonrotoclaxBTK CDAC2025

2025(US GAAP)

BeOneONC

?2024

2024? 3855.0%? GAAPGAAP?

?202426104.9%? BCL2sonrotoclaxBTK CDAC BGB-16673? 13NME? 2025

2025113432025GAAP20241227(FDA)

?PD-L1≥1HER220241223202512ONC20241212SYH2039SYH20392A(MAT2A)20241127

?20241119MSN Pharmaceuticals, Inc.MSN Laboratories Private Ltd.

MSN

?20241114BeOne Medicines Ltd.

?2024

3,700CROCRO

1,10015MoACDACADC

CDAC

??

?

357,100

??

sonrotoclaxBTK-CDACCLLB

BTK-CDAC

?

sonrotoclaxCLL

CLL

?2024

PD-1

PD-1

?

???

2024123126202373%20252024GAAPGAAP2024

?2024

202420231231

202420231231

123120242023%

3,779,5462,189,8521,589,69472.6% 30,695268,927(238,232)(88.6)%

3,810,2412,458,7791,351,46255.0%

594,089379,920214,16956.4%3,216,1522,078,8591,137,29354.7% 1,953,2951,778,594174,7019.8% 1,831,0561,508,001323,05521.4%

3,784,3513,286,595497,75615.1%

(568,199)(1,207,736)639,537(53.0)% 47,83674,009(26,173)(35.4)% (12,638)307,891(320,529)(104.1)%

(533,001)(825,836)292,835(35.5)%111,78555,87255,913100.1%

(644,786)(881,708)236,922(26.9)%

20231231252024123114

??

2023

?

2024

12312024%2023%1,957,49851.4%1,128,21945.9%1,950,53051.2%945,55138.5%6,9680.2%182,6687.4%1,411,30737.0%1,101,95144.8%1,390,69936.5%1,093,09144.5%20,6080.5%8,8600.3%362,6269.5%202,0148.2%359,5079.4%122,2285.0%3,1190.1%79,7863.2%78,8102.1%26,5951.1%78,8102.1%28,9821.2%––%(2,387)(0.1)%3,810,241100.0%2,458,779100.0%

123120242023%?

2,644,2261,290,3961,353,830104.9%?

620,836536,62084,21615.7%?

224,40392,828131,575141.7%?

74,33154,34219,98936.8%?

66,17139,79926,37266.3%?

53,50956,547(3,038)(5.4)%?

36,02876,018(39,990)(52.6)%

60,04243,30216,74038.7%3,779,5462,189,8521,589,69472.6%

?2024

202412313822

???

202420241231

?

26104.9%202412

?

209.456106.3%?

CLLCLL

20243,00020241231

?

3.588193.6%

20241231

?

2.581

33.2%

20241231

?

6.20815.7%

?2025202412310.307

202312312.689

202412313284.3%202312311882.7%

??3,27020241231

83.2%85.5%

?2024

20231231181.7479.8%2024123120202420231231

123120242023%

539,446551,417(11,971)(2.2)% 114,04946,80067,249143.7%

75,16553,31521,85041.0%728,660651,53277,12811.8%1,224,6351,127,06297,5738.7%1,953,2951,778,594174,7019.8%

1,668,3681,558,960109,4087.0%

1. 202412311.4847,520

7,3202.

GAAPGAAP2024123120241231119,7608.7%12

202412312,710

?2024

123120242023%1,831,0561,508,001323,05521.4%

1,549,8641,284,689265,17520.6%1.

GAAPGAAP20231231153.23121.4%2024123118

?2024123148.4%

68.9%

202312317,4002,62035.4%202412314,780

?2024

202412311,260

202312313.079BMS

3.629

202412311.118202312315,59020241231

1,2102024

202112(OECD)

?

2024

GAAP

123120242023GAAPGAAP594,089379,920

42,7078,578

4,7293,739546,653367,603GAAPGAAP1,953,2951,778,594

186,113163,550

98,81456,0841,668,3681,558,960GAAPGAAP1,831,0561,508,001

255,680204,038

25,41715,774953,5001,549,8641,284,689GAAPGAAP3,784,3513,286,595

441,793367,588124,23171,858

953,5003,218,2322,843,649GAAPGAAP(568,199)(1,207,736)

441,793367,588166,93880,4364,8247,23945,356(752,473)

?

2024

20241231(i)11(ii)10013(iii)141.5

20231231358.088.9%20241231676.3

20231231416.119.0%20241231495.0

20231231257.525.1%20241231

192.9(i)(ii)(iii)

202312311,324.219.2%202412311,578.4

20231231125.428.0%20241231160.5

202420231231405.0315.1

?2024

1231202420233401,252302,310368718,205612,6154,551125945

404,997315,111

202420231231

123120242023248,348217,803235,600139,936154,269162,969

77,53087,57231,10636,20334,90430,08321,95619,165803,713693,73120231231693.715.9%20241231

803.7

20231231886.014.9%202412311,018.0

20241231

?2024

202420231231

1231202420232,638,7473,185,9841,018,013885,9842024202312316920241231862024

2024123112

2024123110

(BeiGene, Ltd.)7.62112202412312025

20211215

202412316

?2024

202420231231

1231202420233,185,9843,875,037

(140,631)(1,157,453)(548,350)60,004

193,449416,478(51,705)(8,082)(547,237)(689,053)2,638,7473,185,984

202412315.4846,000

202412311.9344.165

20258.515

?2024

202412311,650

20241231

68,53419,82448,710131,944110,42321,5211,018,013851,529166,48455,23039,85615,374335,261225,251110,0107,4041,8385,56616,4053,92212,48348,34748,347–1,681,1381,300,990380,148

?2024

202412311.3193,2509,940

128.5151.665

20241231

12.5

20241231

3.353

?2024

20241231740

202412311,6402025390

202412314,830

?

2024

NRDL

?2024

20241231100

?

2024

ADS202420231231

202412317.20120241231100720

20052024202312

312.8%

?2024

2024202312311,6006,480

20241231

2.2042024123110%2,000

20241231

202412312023123125.0%30.6%

20241231

?2024

20241231

20241231

2024123111,0002023123110,500

2024123118202316

2024123111.32023123114.2

144.92023

1231200.4

2024123120231231

20241231

?2024

112025

Olivier Brandicourt69Margaret Han Dugan68Michael Goller50Anthony C. Hooper70Ranjeev Krishana51Alessandro Riva64Corazon (Corsee) D. Sanders68Shalini Sharp50

5720101020052009BioDuro, LLCPharmaceutical ProductDevelopment Inc.20022004Galenea Corp.

19982002Telephia, Inc.2007(The Nielsen Company)19971998Genta Inc.

(McKinsey & Company)1990619961

?2024

62201622011

20032010202019972010Howard Hughes Medical Institute20012010

George L. MacGregor2004JoyantPharmaceuticals, Inc.219719847

1991520042013

?2024

Olivier Brandicourt6920241Brandicourt201911Blackstone Life SciencesBlackstone GroupBrandicourtAlnylam Pharmaceuticals, Inc.RNAi

Dewpoint Therapeutics, Inc.AvenCell Therapeutics, Inc.

CAR-TBrandicourt30

2015420198Sanofi S.A.Sanofi20131120153Bayer HealthCare AG20002013Pfizer Inc.

SanofiBrandicourt201920172019BrandicourtBrandicourtBrandicourt

Margaret Han Dugan6820222DuganSchrodinger,Inc.SDGR2018Dracen20DuganAmerican CyanamidDuganDugan

?2024

Michael Goller5020154GollerBaker Brothers Investments2005Baker BrothersGoller19992003JPMorgan Partners,LLC19971999Goller(MerrillLynch and Co.)GollerDBV Technologies SA

Replimune Group, Inc.REPL20172019Levo Therapeutics, Inc.Goller19975

20055

GollerAnthony C. Hooper7020201Hooper20201201892020120112018820102011HooperBristol Myers Squibb Company (BMS)20092010HooperBMS20042009HooperBMSHooperBMS

BMSHooperHooper19781988MBAHooperMannKind CorporationMNKDHooper

Ranjeev Krishana5120141020202Krishana2011Baker Bros. Advisors LPBaker Bros.Krishana(Pfizer, Inc.)

Krishana200320072008201120082010KrishanaKrishanaAccenture plcKrishanaImmunocore Holdings plc

IMCRKrishana1995520116Krishana

?

2024

Alessandro Riva642022220212023RivaIntimaBioscience, Inc.20192021

Ichnos Sciences

20172019Riva

Kite Pharma20052016Riva

GSKRivaBicycle Therapeutics plcBCYCCenturyTherapeutics, Inc.IPSC

iPSCNKTRivaTransgene SATNGTNG

Farmitalia Carlo ErbaRh?ne-Poulenc RorerAventis(BCIRG)(CIRG)RivaRivaCorazon (Corsee) D. Sanders6820208Sanders(Bristol Myers Squibb Corporation)201911

20202Sanders20183201911

2017120183Juno Therapeutics

19942017SandersGenentechGenentech(Late StagePortfolio Committee)Genentech(Late Stage Clinical Operations)GenentechGenentechGenentech DATA

Sanders(Fred Hutchinson CancerResearch Center)(Board of Trustees)Legend Biotech CorporationLEGNAltruBio Inc.AbGenomicsUltragenyx Pharmaceutical Inc.RARESanders(Magna Cum Laude)Sanders

?

2024

Shalini Sharp5020249SharpNeurocrine Biosciences, Inc.NBIXOrganon & CoOGN

Septerna, Inc.LEGN20125202010SharpUltragenyx Pharmaceuticals Inc.2003820125SharpAgenus, Inc.

2012520186SharpElanPharmaceuticalsMcKinsey & CompanySharp20213Mirati Therapeutics, Inc.20241201811202311

Sutro Biopharma, Inc.20181220226Precision BioSciences, Inc.20207Panacea Acquisition Corp.

20211Nuvation Bio20174Array Biopharma20196SharpSharp

532014106618(Hillhouse Capital)2005

1995720035

?2024

2025418

Aaron Rosenberg48

Chan Lee57

6320184202141

20184200920184201720184(Pfizer Essential Health)

2004200920012004199220082018(RDPAC)20152018

(NDPE)2017201720171993419901

?2024

Aaron Rosenberg4820247Rosenberg

2021Rosenberg20182021Rosenberg20152018120

2003Rosenberg

482021420115

2010Joyant Pharmaceuticals19962001Chan Lee5720227Lee2520162022Lee

20082016LeeLeeLee

?2024

13.51(B)(1)

20241231

13.51(B)(1)

Thomas Malley2024122Olivier Brandicourt202412320243

Shalini Sharp202492720251

16202531Donald W. Glazer20241025Anthony C. Hooper2025116202531

?2024

20241231

2010102820188806160201623202511BGNE202512

ONC20211215688235

?????EUSA Pharma

164168

20241231

?2024

20241231267

2024123161.9%

18.0%20231231

61.3%16.0%20242023123130.1%26.4%

20242023123111.8%8.0%202412315%

?2024

20241231

Shalini SharpAnthony C. Hooper

2025116202531Shalini SharpAnthony C. Hooper2025310

???

?2024

??????????

?2024

????????

?2024

?

?

?

??

?

2024

????

202012

174.8515,895,001206,635,013

20.5%2,779,241,000(a)201910303036%(b)

1.007.842019103126%(c)2019103126%

?2024

2019112920241231

20231231

20241231

20241231

(a)

2,779,241100%2,229,6322,357,788421,453(a) 12.5

20191129

202620191112019129202013

?2024

2021121520216162021

192.60

234.89391.68115,055,260

3,392,616,000

(i)(ii)(iii)(iv)(v)20231110

2020111620211292021420202151420216120216212021628202163020217920217282021101520211116202111232021112420211129202111302021122202112620211272021121320211221202112282022429202262720228302022928202342520238292023111320244262024829202411122021430

?2024

2024123117937

20241231

20231231

20241231

20241231

13,245,9407,169,47010,045,5103,200,430467,700434,188485,741(18,041)*150,000153,451153,451(3,451)*136,360110,240143,560(7,200)*6,000,0004,832,2815,624,969375,0311,630,155978,0001,467,000163,15521,630,15513,677,63017,920,2313,709,924

*

?2024

2024123120241231270

2929

?2024

202412319

202412311,018.02023886.0

202412315.020235.4

20241231

20241231

?2024

20241231

Olivier Brandicourt

Margaret Han DuganMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. SandersShalini Sharp

(1) 2024123Olivier Brandicourt

(2) 2024927Shalini Sharp* 2024122Thomas MalleyMalley

MalleyMalley

?2024

20241025Donald W. Glazer

2026202720252025Anthony C. HooperRanjeev KrishanaShalini SharpShalini Sharp20249

Shalini Sharp2025Shalini Sharp2027Shalini Sharp(i)20248203.09D(ii)

202412313.13

?2024

2024319

65,0002023

20,00020232,00010,0002023

1,0002024412023

65,00035,00017,50030,00015,00020,000

(1)

10,000

(2)20,00010,00020,00010,000

(1) 20232,000

(2) 20231,000

?

2024

400,000

400,00050%50%

(i)(ii)20162016

1,000,0002019220249

202320241231

27.523.1

242526

?2024

20174251,133,000

100%

(i)(ii)(iii)

(iv)(i)(ii)12(iii)(iv)20,000(v)

20201224

?2024

2010201872420212242023127202411202612312024100,000202420241120261231

302024

2024

20241231

?2024

20241231

20241231

20241231

20241231

8.10

?2024

20241231XV

(a)XV78

(b)352(c)

(1)28,433,383

(2)

2.05%

9,545,000

(3)

0.69%

102,188

(4)

0.01%

7,727,927

(5)

0.56%

28,204,115

(6)

2.04%

510,941

(7)

0.04%

481,533

(8)

0.03%

1,274,117

(9)

0.09%

14,276,631

(10)

1.03%

4,058,998

(11)

0.29%

1,025,063

(12)

0.07%

(13)

0.000004%

Olivier Brandicourt78,286

(14)

0.01%

Margaret Han Dugan164,307

(15)

0.01%

Michael Goller503,724

(16)

0.04%

Anthony C. Hooper234,377

(17)

0.02%

Ranjeev Krishana503,724

(18)

0.04%

Alessandro Riva164,307

(19)

0.01%

Corazon (Corsee) D. Sanders186,992

(20)

0.01%

Sharp Shalini25,389

(21)

0.002%

486,642

(22)

0.04%

?

2024

(1) 202412311,384,840,687

2,527,017

(2) (1)2,017,987(2)24,473,622

(3)960,846

(4)980,928

(3) Roth IRA PENSCO

(4) The John Oyler Legacy Trust

(5)

(6) Oyler Investment LLC

Oyler Investment LLC 99%

(7) The Oyler Family Legacy Trust

(8)(9)

(10) (1)5,015,703(2)9,035,749

(3)225,179

(11) Wang Investment LLCWang Investment LLC99%(12)

?2024

(13)

(14) (1)BrandicourtBrandicourt61,945

(2) Brandicourt16,341

(15) (1)Dugan29,614(2)DuganDugan118,352(3) Dugan16,341

(16) (1) Goller46,696(2)GollerGoller440,687(3) Goller16,341

(17) (1) Hooper24,492(2)HooperHooper

180,622(3) Hooper29,263

(18) (1) Krishana46,696(2)KrishanaKrishana

440,687(3) Krishana16,341

(19) (1) Riva29,614(2)RivaRiva118,352

(3) Riva16,341

(20) (1) Sanders29,900(2)SandersSanders

140,751(3) Sanders16,341

(21) (1)SharpSharp17,238

(2) Sharp8,151

(22) (1)29,614(2)440,687

(3)16,34120241231

(a)XV7

(b)352(c)

?2024

20241231

XV23

(1)Amgen Inc.246,269,42617.78%Julian C. Baker

(2)

125,377,5949.05%Felix J. Baker

(2)

125,377,5949.05%Baker Bros. Advisors (GP) LLC

(2)

124,921,9349.02%Baker Bros. Advisors LP

(2)

124,921,9349.02%Baker Brothers Life Sciences Capital, L.P.

(2)

114,632,5048.28%HHLR Advisors, Ltd.

(3)

111,597,4238.06%HHLR Fund, L.P.

(3)

111,597,4238.06%The Capital Group Companies, Inc.

(4)

96,385,8916.96%JPMorgan Chase & Co.

(5)

24,061,5671.74%21,150,519(S)1.53%(S)3,373,4180.24%

126,5200.01%

4,7580.0003%106,282,4197.67%

(S)

(1) 202412311,384,840,6872,527,017

(2) Julian C. BakerFelix J. BakerBaker Bros. Advisors (GP) LLCBaker Bros. Advisors (GP) LLC

Baker Bros. Advisors LPBBABBA667, L.P.Baker Brothers Life Sciences, L.P.Baker Brothers Life Sciences Capital, L.P.Baker Brothers Life Sciences, L.P.

BBAMichael GollerRanjeev Krishana

BBA

?

2024

Baker Brothers Life Sciences Capital, L.P.Baker Bros. Advisors (GP) LLCJulian C. BakerFelixJ. Baker202412112024129113,625,056Baker Brothers Life Sciences, L.P.Julian C. BakerFelix J. BakerBaker Bros. Advisors (GP) LLCBBA667, L.P.10,289,430BakerBrothers Life Sciences, L.P.113,625,056723,996BBABaker Brothers Life Sciences Capital, L.P.

Baker Brothers Life Sciences, L.P.113,625,056723,996BBAJulian C. BakerFelix J. Baker270,868FBB3 LLC144,517

(3) (i) 111,597,423HHLR Fund, L.P.YHG Investment, L.P.(ii) 13,447,603HillhouseBGN Holdings LimitedHHLR Advisors, Ltd.YHG Investment, L.P.HHLR Fund,L.P.Hillhouse Capital Management, Ltd.Hillhouse Fund II, L.P.Hillhouse Fund II, L.P.Hillhouse BGN Holdings LimitedHHLR Advisors, Ltd.

HHLR Fund, L.P.YHG Investment, L.P.111,597,423Hillhouse CapitalManagement, Ltd.Hillhouse BGN Holdings Limited13,447,603Hillhouse Fund II, L.P.Hillhouse BGN Holdings Limited13,447,603

(4) (i) 7,311,624Capital International, Inc.(ii) 1,052,088Capital International Limited

(iii) 2,096,140Capital International Sarl(iv) 83,338,123Capital Research andManagement Company(v) 227,090Capital Group Investment Management Private Limited

(vi) 2,360,826Capital Group Private Client Services, Inc.Capital Group International, Inc.Capital Research and Management CompanyCapitalInternational, Inc.Capital International LimitedCapital International SarlCapital Group InvestmentManagement Private LimitedCapital Group Private Client Services, Inc.Capital Group International,Inc.Capital Bank and Trust CompanyThe Capital Group Companies, Inc.Capital Research and Management CompanyCapital Group International, Inc.CapitalInternational, Inc.Capital International LimitedCapital International SarlCapital Group InvestmentManagement Private LimitedCapital Group Private Client Services, Inc.13,047,768Capital Research and Management CompanyThe Capital Group Companies Inc.The Capital Group Companies Inc.Capital Research and Management Company96,385,891

(5) JPMorgan Chase & Co.20241211JPMorgan Chase & Co.133,848,68221,150,519106,282,419523,9961,035,265

20241231

XV23

?2024

201120162018201120162024652018202465

20231231

202465202420162018

201620162018201817201620182024426

202465(i)201692,820,000

2016(ii) 35,169,0942016(iii)20185,070,0002018

(iv) 919,6782018202465202412312024123188,017,857

20,409,697201620182016201820162018202465202412318,437

2024123120,401,260

20246520241231

?2024

58,873,893

4.25%202493202522820182025228

1. 2011

20114152015417201120162220162011

2011

201143,560,4322016222016

201120241120111,427,68620111,186,666202412312025418240,94377,37620254180.1%2011

?

2024

20112011

2011

2011

0.011.85

2011

20112016222016201120112018730

?2024

2011

2024123120112402011

20115202016131202411202412312011

2024

20241231

2015629

(1)

100.50500,000499,993

(8)

Thomas Malley*2016125

(2)

(6)

1.85552,752552,747

(4)

2015629

(3)

100.501111

2011520 2016 131

(3)

100.01

1.85

327,621130,143

(5)

67197,4112011520 2016 131

(3)

100.01

1.85

47,3023,783

(7)

543,514

1,427,6861,186,666–77240,943

* Thomas Malley2024122

?2024

(1) 20%80%20%48(2)

(3) 20%/25%80%/75%20%/25%48/36

(4) 1312.3913.08

(5) 1310.9115.90

0.301.85

(6) Thomas Malley2024122Thomas Malley

20241232024122

(7) 1310.97

0.01

(8) 1314.62

0.50

2. 20162024652016

201618

2016

?2024

2016

2016

(i)(ii)(iii)(iv)(v)(vi)(vii)

202411201637,575,472202411202464

4,732,637201620246520162016

2024652024123154,141,25620168,43720241231202541883,064,17584,979,82920,401,26020,401,2602016

?2024

2024112016165,493,25520162024112024644,282,8892024652016

2016

20162024652024123120,751,666202412312025418233,278,768225,542,962202541816.07%2016

20162016121%

?2024

(1)(2)(3)(4)(5)(6)

(7) 12

?2024

2016(x)

(y)

2016

2016201620304132016520162016

20241231201620161,2042016201620162820241231

201620160.5

28.81

?2024

20241161,516,76020162024123164,383,9262016

(1)(2)

2024

20241231

2016

1116(3)

2.792.842,047,500––––2,047,5002017

(3)

6.737.70935,000––––935,0002018

(3)

13.3713.04996,810––––996,8102018

(3)

12.7012.341,310,088––––1,310,0882019

(3)

9.259.232,193,282––––2,193,2822020

(3)

13.3313.421,821,976––––1,821,9762021

(3)

25.5426.53906,906––––906,9062022

(3)

11.7411.981,887,678––––1,887,6782023

(3)

16.0116.411,349,907––––1,349,9072024

(3)

11.9312.23–923,975–––923,9752016

1116

(3)

2.792.841,613,430––––1,613,4302017927

(3)

6.737.70750,000––––750,0002018

(3)

12.7012.34655,044––––655,0442019

(3)

9.259.23747,708––––747,7082020

(3)

13.3313.42560,599––––560,5992021

(3)

25.5426.53241,839––––241,839

?2024

(1)(2)

2024

202412312022

(3)

11.7411.98471,913––––471,9132023

(3)

16.0116.41327,249––––327,2492024

(3)

11.9312.23–410,657–––410,657Anthony C. Hooper

2020

(5)

12.6212.2221,970––––21,9702020

(5)

13.3313.4245,383––––45,3832021

(5)

25.5426.5317,498––––17,4982022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151Olivier Brandicourt

2024

(5)

13.7312.74–27,794–––27,7942024

(5)

11.9312.23–34,151–––34,151Margaret Han Dugan

2022

(5)

16.4716.2222,581––––22,5812022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151Donald W. Glazer*

2017

(4)

2.842.83199,992––––199,9922018

(5)

15.7316.1517,442––––17,4422019

(5)

9.259.2364,610––––64,610

?2024

(1)(2)

2024

202412312020

(5)

13.3313.4245,383––––45,3832021

(5)

25.5425.6317,498––––17,4982022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151Michael Goller2017

(4)

2.842.83199,992––––199,9922018

(5)

15.7316.1517,442––––17,4422019

(5)

9.259.2364,610––––64,6102020

(5)

13.3313.4245,383––––45,3832021

(5)

25.5425.6317,498––––17,4982022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151Ranjeev Krishana

2017

(4)

2.842.83199,992––––199,9922018

(5)

15.7316.1517,442––––17,4422019

(5)

9.259.2364,610––––64,6102020

(5)

13.3313.4245,383––––45,3832021

(5)

25.5425.6317,498––––17,4982022

(5)

11.7411.9834,645––––34,645

?

2024

(1)(2)

2024

202412312023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151

Thomas

Malley**

2017

(5)

(10)

2.9413.083.15169,988–169,988–––2018

(5)

(10)

15.7316.1517,442––––17,4422019

(5)

(10)

9.2513.099.2364,610–64,610–––2020

(5)

(10)

13.3313.4245,383––––45,3832021

(5)

(10)

25.5425.6317,498––––17,4982022

(5)

(10)

11.7411.9834,645––––34,6452023

(5)

(10)

16.0116.4126,975––––26,975Corazon D.Sanders

2020

(5)

18.5018.2627,482––––27,4822021

(5)

25.5425.6317,498––––17,4982022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151

–Alessandro

Riva

2022

(5)

16.4716.2222,581––––22,5812022

(5)

11.7411.9834,645––––34,6452023

(5)

16.0116.4126,975––––26,9752024

(5)

11.9312.23–34,151–––34,151

?2024

(1)(2)

2024

20241231Shalini Sharp2024930

(5)

16.8017.27–17,238–––17,2382017419

(4)

2.842.83199,992––––199,992201866

(5)

15.7316.1517,442––––17,442201965

(5)

9.259.2364,610––––64,6102020617

(5)

13.3313.4245,383––––45,3832021616

(5)

25.5425.6317,498––––17,4982022622

(5)

11.7411.9834,645––––34,6452023615

(5)

16.0116.4126,975––––26,975202465

(5)

11.9312.23–34,151–––34,151

–2018430

(6)

13.3713.04766,599––––766,599201965

(3)

9.259.23797,550––––797,5502020617

(3)

13.4213.33756,821––––756,8212021616

(3)

25.5425.63483,678––––483,6782022622

(3)

11.7411.981,061,814––––1,061,8142023615

(3)

16.0116.41760,851––––760,851202465

(3)

11.9312.23–477,386–––477,386

?2024

(1)(2)

2024

20241231***2020630

(3)

(11)

14.5514.66104,754––––104,7542021616

(3)

(11)

25.5426.53177,853––––177,8532022

(3)

(11)

11.7411.98589,888––49,296–540,5922023

(3)

(11)

16.0116.41409,058––136,500–272,5582024

(3)

(11)

11.9312.23–256,659–256,659––Aaron

Rosenberg

2024

(3)

14.0814.06–220,987–––220,9872018

(3)

12.7012.34364,208––––364,2082019

(3)

9.259.23558,285––––558,2852020

(3)

13.3313.42525,564––––525,5642021

(3)

25.5426.53332,527––––332,5272022

(3)

11.7411.98707,876––––707,8762023

(3)

16.0116.41507,234––––507,2342024

(3)

11.9312.23–318,253–––318,253Chan Lee

2022

(3)

2.262.27188,929––––188,9292023

(3)

16.0116.41248,950––––248,9502024

(3)

11.9312.23–184,795–––184,795

?2024

(1)(2)

2024

202412312016

(3)

2.272.29200,000–––200,0002024

(12)

13.7312.74–16,380––16,3802016

(3)

2.2715.492.292,754,293–616,642–72,137,6442016

(3)

2.1315.122.1068,827–49,218–1219,5972016

(6)

2.1314.982.10732,232–114,140–27618,0652016

(3)

2.112.023––3––2016

1012

(3)

2.482.426–––62016

1017

(3)

2.4212.062.5556,212–56,212––2016

1130

(3)

2.432.441,274–––1,2742016

(3)

2.072.0934,099–––34,0992017

(3)

2.342.397,800–––7,8002017

(6)

2.5114.882.5335,763–27,521––8,2422017

(3)

2.682.77144,989–––144,9892017

(3)

2.762.7632,201–––32,2012017

(3)

2.7712.392.779,243–7,800–1,4432017

(3)

3.083.02116,701–––116,7012017

(3)

3.0415.003.0469,368–42,458–26,9102017

(6)

2.8116.082.8228,704–7,904–20,800

?2024

(1)(2)

2024

202412312017

(6)

3.1315.413.12100,854–1,950–98,9042017

(3)

3.123.1211,999–––11,9992017

(6)

2.8314.452.94147,914–109,525–38,3892017

(3)

2.9911.853.0012,727–12,727––2017

(3)

3.0415.203.05407,160–64,480–342,6802017

(6)

3.0515.063.042,747,446–495,378––2,252,0682017

(3)

3.5015.763.492,132,624–117,208–2,015,4162017

(3)

3.503.4533,657–––33,6572017

(3)

5.4013.005.451,300–1,300––2017

(6)

5.6715.054.19234,130–61,282–172,8482017

(3)

5.5813.085.4260,996–60,996––2017

(6)

5.5815.455.42285,519–62,998–222,5212017

(3)

5.4215.855.5839,000–39,000––2017

(3)

5.455.5119,994–––19,9942017

(3)

5.5615.955.9539,000–39,000––2017

(3)

5.295.2824,167–––24,167

?2024

(1)(2)

2024

2024123120178

(6)

5.3015.525.30168,168–29,744–138,424201795(3)

5.785.6835,009–––35,00920179

(3)

6.226.3722,269–––22,26920179

(3)

6.5512.616.56121,992–70,499–51,49320179

(3)

7.4913.917.9637,492–37,492––201711

(3)

7.1012.166.84199,056–108,862–90,194201711

(3)

6.386.1510,764–––10,764201815

(3)

7.727.5819,071–––19,07120181

(3)

9.5210.4480,017–––80,01720184

(3)

13.3713.046,149–––6,149201866(5)

15.7316.1517,442–––17,44220186

(3)

12.7014.4412.34641,433–128,726–512,70720186

(3)

11.9011.8312,103–––12,10320188

(7)

13.6713.666,708–––6,70820189

(3)

13.2813.2565,433–––65,43320189

(8)

13.2813.2539,260–––39,260201811

(3)

11.0711.7911,028–––11,028201812

(3)

10.5314.0210.79107,016–7,800–99,216

?

2024

(1)(2)

2024

2024123120181231

(8)

10.5313.8510.7912,194–12,194––2019

(3)

9.6210.4438,649–––38,6492019

(3)

11.6812.4111.5178,494–78,494––2019

(3)

9.3310.3244,213–––44,2132019

(3)

9.2514.189.231,865,240–349,687–1,515,5532019

(5)

9.259.23129,220–––129,2202019

(3)

11.1413.7511.0679,300–4,641–74,6592020

(3)

9.659.67294,775–––294,7752020

(3)

13.3314.6313.421,182,181–83,0313,09436,4261,059,6302020

(5)

13.3313.4290,766–––90,76620206

(3)

14.5514.66212,771–––196,40416,3672020

(3)

17.2416.9940,248–––40,2482020

(3)

21.6522.038,021–––8,0212020

(3)

23.0823.07162,994––––162,9942020

1130

(3)

21.9920.9915,756––3,04212,714–2021

(3)

27.4628.8155,263––1,0533,95250,2582021

(3)

25.3625.816,331––1,6384,693–20213

(3)

25.6126.78148,824––3,90024,700120,224

?2024

(1)(2)

2024

20241231

2021

(3)

24.1524.7884,240–––84,2402021

(3)

27.0027.58121,485–––121,4852021

(3)

25.5426.531,608,737––37,089177,7621,393,8862021

(5)

25.5426.5317,498––––17,4982021

(3)

27.4827.2848,113––5,0059,03534,0732021

(3)

25.8425.6168,341––––68,3412021

(3)

23.2223.72153,322––7,163126,25619,9032021

(3)

27.8128.7355,458––2,483–52,9752021

(3)

28.3828.0823,231––3,9527,20212,0772021

1130

(3)

26.4026.8564,649––5,6555,92853,0662021

1231

(3)

21.0320.8426,637––4,8365,21316,5882022

(3)

17.2718.61371,059––3,627367,4322022

(3)

16.4718.8116.22151,580––––151,5802022

(3)

15.8515.46135,694–––135,6942022

(3)

12.2715.3112.5063,349–8,125–55,2242022

(3)

10.3015.3110.56123,604–4,589–119,0152022

(3)

11.7414.3711.985,102,089–530,439332,293117,3124,122,0452022

(9)

11.7411.9811,804–––11,804

?2024

(1)(2)

2024

20241231

2022

(3)

12.4813.8812.8174,217–1,4046,13666,6772022

(3)

12.7313.3222,009–––22,0092022

(3)

10.4810.5863,024–––63,0242022

1110

(3)

13.5614.5246,176–––46,176202211

(3)

13.8414.7417,745–––17,7452022

1230

(3)

17.2217.267,592––4,2903,302–2023

(3)

20.5220.6429,471––4,5501,50823,4132023

(3)

16.6217.2861,724–––61,7242023

(3)

16.6717.8116.9951,844–3,23713,1042,32733,1762023

(3)

20.0520.0618,395––3,9651,59912,8312023

(3)

17.5617.9819,188–––19,1882023

(3)

16.0117.8516.415,183,529–97,136420,83613,2214,652,3362023

(3)

13.7413.8230,277–––30,2772023

(3)

14.6016.0866,729–––66,7292023

(3)

16.2515.9754,314––16,14638,1682023

(3)

14.1715.8614.51192,686–4,64126,234161,8112023

1113

(3)

15.3215.3024,297–––24,2972023

1130(3)

14.0914.3832,968––22,38610,582

?2024

(1)(2)

2024

2024123120231229

(3)

13.8113.8750,271––11,07639,1952024

(3)

12.4812.40–49,673–12,18137,4922024

(3)

13.7312.74–12,012––12,0122024

(3)

11.9312.03–74,464––74,4642024

(3)

12.9712.59–155,792––155,7922024

(3)

11.8711.81–145,340––145,3402024

(3)

11.9312.23–5,011,318–382,2654,629,0532024

(3)

11.2011.67–22,880––22,8802024

(3)

14.0814.06–75,868––75,8682024

(3)

15.2415.26–48,802––48,8022024

(3)

16.8017.27–278,031––278,0312024

1114

(3)

15.0315.48–47,164––47,1642024

1129

(3)

15.8616.54–67,951––67,9512024

1231

(3)

14.1414.21–29,523––29,523

61,516,7609,180,3013,783,0781,780,457749,60064,383,926

?2024

* Donald W. Glazer20241025** Thomas Malley2024122*** 2024719

(1) 13

(2) 13

(3) 25%

75%25%36(4)(5)

Thomas Malley2024122Thomas Malley20241232023615Thomas Malley

20241232024630

(6) 20%80%20%48

(7) 48(8)

(9) 50%50%50%12

?2024

(10) Thomas Malley2024122Thomas Malley

Thomas Malley

(11) 2024717

(12)

?2024

20162016

(3)

923,975202465(1)12.23–11.935,999,924410,657202465(1)12.23–11.932,666,642Anthony C. Hooper34,151202465(2)12.23–11.93199,995Olivier Brandicourt27,7942024229(2)12.74–13.73158,862

34,151202465(2)12.23–11.93199,995Margaret Han Dugan34,151202465(2)12.23–11.93199,995Donald W. Glazer*34,151202465(2)12.23–11.93199,995Michael Goller34,151202465(2)12.23–11.93199,995Ranjeev Krishana34,151202465(2)12.23–11.93199,995Corazon D. Sanders34,151202465(2)12.23–11.93199,995Alessandro Riva34,151202465(2)12.23–11.93199,995Shalini Sharp17,2382024930(2)17.27–16.80140,779

34,151202465(2)12.23–11.93199,995

477,386202465(1)12.23–11.933,099,954**256,659202465(1)12.23–11.931,666,641Aaron Rosenberg220,987202489(1)14.06–14.081,666,662

318,253202465(1)12.23–11.932,066,608Chan Lee184,795202465(1)12.23–11.931,199,985

6,018,8182024124

20241231

(1)11.67-

17.27

–11.20-

16.80

40,186,26216,3802024229(4)12.74–13.7399,9529,180,30160,752,226

?2024

* Donald W. Glazer20241025** 2024719

(1) 25%

75%25%36

(2)

(3)

(4) 100%

20162016202412312016201617,828

3220162016

201792620241231

?

2024

20241166,401,02320162016

2024123183,668,5852,162,08220162016

2024

20241231

2024(1)

2021616(6)25.5473,138–36,556–36,58212.51

2022622(6)11.74250,510–83,499–167,01112.012023615(6)16.01355,641–88,907–266,73412.51202465(6)11.93–490,464––490,464–202465(9)11.93–490,464

(10)

––490,464–2021616(6)25.5419,500–9,750–9,75012.512022622(6)11.7462,634–20,865–41,76912.012023615(6)16.0186,216–21,554–64,66212.51202465(6)11.93–108,992––108,992–Anthony C. Hooper2022622(7)11.7416,692–16,692––14.14

2023615(7)16.0112,922–––12,922–202465(7)11.93–16,341––16,341–Olivier Brandicourt202465(7)11.93–16,341––16,341–Margaret Han Dugan2023615(7)16.0112,922–12,922––11.93

202465(7)11.93–16,341––16,341–Donald W. Glazer*2022622(7)11.7416,692–16,692––14.14

2023615(7)16.0112,922–––12,922–

202465(7)11.93–16,341––16,341–

?2024

2024

20241231

2024(1)Michael Goller2023615(7)16.0112,922–12,922––11.93

202465(7)11.93–16,341––16,341–Ranjeev Krishana2023615(7)16.0112,922–12,922––11.93

202465(7)11.93–16,341––16,341–Thomas Malley**2023615(7)16.0112,922––12,922––Corazon D. Sanders2023615(7)16.0112,922–12,922–––

202465(7)11.93–16,341––16,341–Alessandro Riva2023615(7)16.0112,922–12,922–––

202465(7)11.93–16,341––16,341–Shalini Sharp2024930(7)16.80–8,151––8,151–

2023615(7)16.0112,922–12,922–––

202465(7)11.93–16,341––16,341–

?

2024

2024

20241231

2024(1)

2020617(6)13.3333,566–33,566––12.012021616(6)25.5439,000–19,500–19,50012.012022622(6)11.74140,907–46,969–93,93812.512023615(6)16.01200,447–50,102–150,34512.01202465(6)11.93–253,409––253,409–202465(11)11.93–253,409

(10)

––253,409–***2020630(6)14.5513,819–13,819––11.20

2021616(6)25.5414,352–14,352––14.032022228(6)16.4746,319–46,319––14.552022622(6)11.7478,286–52,18226,104–14.032023615(6)16.01107,770–53,87253,898–14.03202465(6)11.93–136,240–136,240––202465(11)11.93–136,240

(10)

–136,240––Aaron Rosenberg202465(6)14.08–118,547––118,547–

202465(11)14.08–118,547

(10)

––118,547–2020617(6)13.3323,309–23,309––12.512021616(6)25.5426,819–13,403–13,41612.512022622(6)11.7493,951–31,304–62,64712.012023615(6)16.01133,627–33,397–100,23012.51202465(6)11.93–168,935––168,935–202465(11)11.93–168,935

(10)

––168,935–Chan Lee

2022729(6)13.4587,009–29,003–58,00612.502023615(6)16.0165,585–16,393–49,19212.51202465(6)11.93–98,085––98,085–202465(11)11.93–98,085

(10)

––98,085–

?2024

2024

20241231

2024(1)

201813120211231

(6)18.558,302,047–5,194,956735,2412,371,850(2)20221120221231

(6)12.2823,899,564–7,592,4812,314,78013,992,303(3)20231120231229

(6)15.6232,088,680–7,600,0473,260,85521,227,778(4)20241120241231

(6)12.21–45,741,4755,8112,228,56443,507,100(5)202465(11)11.93–1,140,269

(10)

–107,6271,032,642–20231120231231

(8)13.818,645–8,645––20241120241231

(12)13.73–16,276––16,276

66,401,02349,693,59221,251,4779,012,47185,830,667

?2024

* Donald W. Glazer20241025** Thomas Malley2024122*** 2024719

(1) 13

(2) 1310.9717.27

(3) 1310.9717.27

(4) 1310.97

16.80

(5) 1310.97

14.75

(6) 25%

(7)

Thomas Malley2024122Thomas Malley(8)

?

2024

(9)

(10) 100%

0200%(11)(12)

?2024

(3)

490,464202465(1)–11.935,999,884490,464202465(5)(6)11.935,999,884108,992202465(1)–11.931,333,308Anthony C. Hooper16,341202465(2)–11.93199,901Olivier Brandicourt16,341202465(2)–11.93199,901Margaret Han Dugan16,341202465(2)–11.93199,901Donald W. Glazer*16,341202465(2)–11.93199,901Michael Goller16,341202465(2)–11.93199,901Ranjeev Krishana16,341202465(2)–11.93199,901Corazon D. Sanders16,341202465(2)–11.93199,901Alessandro Riva16,341202465(2)–11.93199,901Shalini Sharp8,1512024930(2)–16.80140,768

16,341202465(2)–11.93199,901253,409202465(1)–11.933,099,972253,409202465(7)(6)11.933,099,972**136,240202465(1)–11.931,666,634

136,240202465(7)(6)11.931,666,634Chan Lee98,085202465(1)–11.931,199,881

98,085202465(7)(6)11.931,199,881Aaron Rosenberg118,547202489(1)–14.081,666,588

118,547202489(7)(6)14.081,666,588168,935202465(1)–11.932,066,595168,935202465(7)(6)11.932,066,595

45,741,4752024124

20241231

(1)–15.62573,702,3091,140,269202465(7)(6)11.9313,948,998

16,2762024229(4)–13.93219,76449,693,592622,543,364

?

2024

* Donald W. Glazer20241025** 2024719

(1) 25%

(2)(3)(4)(5)

(6) 0200%(7)

?2024

3. 20182024652018

2018201815%

20182018

201820185%

2018

1%10%25,000

?2024

3191

2018

85%

2018

2018

17.03(13)

?

2024

20241120181,941,075202411

2023912024112024641,021,397201820246520182018

202465202412311,035,99620182024123120254184,953,6823,998,2862018

2024123120241231202493

20241120181,941,0752024112024642023911,021,397

201820246520182018202465202412312024311,035,996

20182024123120254184,953,6823,998,2862025418

0.28%2018

2018

20182024652028127

20183.5

20182018

2023912024313,0393,188

20182018

?2024

20182018

202391

202391

(1)(2)

202391610.8310,623.308,307.35

10.83

202391610.8311,808,23511,054,404

10.83

1,020,63011,062,712

?2024

1. 20239115.97125.26

16,414,635128,751,1482023912018

2. 202391

2018202422910.831,021,3972024229

12.7499.7113,014,955101,865,320

3. 20239111,816,543

1,021,397

4. 2018

?2024

202431

202431

(1)(2)

202431610.7910,623.3010,520.03

10.79

202431610.7911,338,41211,167,637.74

10.79

1,035,02111,178,157.76

1. 20243112.7499.71

13,150,774102,939,1302024312018

2018

2. 202431

20182018

202483010.791,035,021202483015.27119.10

15,283,332119,168,419

?

2024

3. 20243111,348,932.47

1,035,996

4. 20182018

20241231

?

2024

Shalini SharpOlivier BrandicourtAnthony C. HooperCorazon (Corsee) D. SandersShalini Sharp

3.10(2)3.21Thomas Malley2024122Malley2024123Olivier BrandicourtMalleyOlivier Brandicourt20241232024927

1112Shalini SharpSalini Sharp2024927

202531Shalini SharpAnthony C. Hooper

20241231

13.2013.2113.22

2025418

?2024

2018882024

2025

2025418

?

2024

20241231

C1C.2.1

Ranjeev Krishana

?2024

3.21D.3.3D.3.7

Shalini SharpOlivier BrandicourtAnthony C. HooperCorazon (Corsee) D. SandersShaliniSharp3.10(2)3.21Thomas Malley

2024122Thomas Malley

2024123Olivier BrandicourtMalleyOlivier Brandicourt

202412320249271112ShaliniSharpSalini Sharp

2024927202531Shalini SharpAnthony C. Hooper

3.25E.1.2

Margaret HanDuganRanjeev KrishanaMargaret Han Dugan

?2024

B.3.1Glazer20241025

3.27A

3.27A2025116ShaliniSharpAnthony C. Hooper

Anthony C. Hooper

3.27A

Anthony C. HooperMichael GollerAlessandro RivaShalini SharpAnthony C. Hooper

C3B.8

202411

?2024

20241231

*Olivier BrandicourtMargaret Han DuganMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. SandersShalini Sharp* 2024122Thomas MalleyMalley

MalleyMalley2024123Olivier Brandicourt2024927Shalini Sharp20241025Donald W. Glazer

?2024

2024

202412313.13

20262027

2025

?2024

?2024

???????

10-K???

?

2024

??

Shalini Sharp2024927202531Olivier Brandicourt2024123Anthony C. Hooper202531

Corazon (Corsee) D. Sanders2024122Thomas MalleyShalini SharpAnthonyC. HooperCorazon (Corsee) D. Sanders3.10(2)

3.21

2024123114

www.beigene.com

202420232024

2024

??

?

?

2024

???????? 10D???

Margaret Han DuganRanjeev KrishanaMargaret Han Dugan

2024123124

8,000,001145,000,000

?2024

20241231245

www.beigene.com

2024

2016201620182018

2016

2016

?????

?2024

??

Michael GollerAnthony C. Hooper2025116Alessandro RivaShalini Sharp2025116Anthony C. Hooper20241025Donald W. Glazer

20241231

www.beigene.com

20242024

3.13

???

?

2024

20241231

Margaret Han DuganMichael GollerAlessandro RivaCorazon (Corsee) D.SandersAlessandro Riva2024122Thomas Malleywww.beigene.com

????

20241231

Olivier Brandicourt2024319Margaret Han DuganAnthony C. HooperRanjeev KrishanaCorazon (Corsee)D. SandersAnthony C. Hooperwww.beigene.com

?

2024

202020222024www.beigene.com

2024123158.2%41.7%

202412

?2024

2024

?2024

(Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay,Grand Cayman KY1-1108, Cayman Islands(a)(b)

193414a-8(b)(2)(c)(d)(e)(f)(i)(ii)

(g)

Aeschengraben 27, 21st Floor, 4051 Basel, Switzerland

?2024

A.2.1

20241231

?2024

20241231

8/81/17/84/41/1Olivier Brandicourt

(1)

8/813/144/41/1Margaret Han Dugan8/86/84/44/41/1Donald W. Glazer

(2)

6/82/21/1Michael Goller8/82/23/41/1Anthony C. Hooper8/814/142/24/41/1Ranjeev Krishana8/88/83/41/1Thomas Malley

(3)

Alessandro Riva8/82/24/41/1Corazon (Corsee) D. Sanders8/814/144/44/40/1Shalini Sharp

(4)

1/83/14

8/88/82/21/1

(1) 2024123Olivier Brandicourt2024319Olivier Brandicourt

(2) 20241025Donald W. Glazer

(3) 2024122Thomas Malley

(4) 2024927Shalini Sharp

?2024

C.2.720241231

2024123120241231

20241231Olivier BrandicourtMargaret Han DuganMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. SandersShalini Sharp

?2024

2024123Olivier Brandicourt20241Olivier BrandicourtOlivier Brandicourt(i)2024112

3.09D(ii)

2024927Shalini Sharp20249Shalini SharpShalini Sharp(i)2024820

3.09D(ii)

202420231231Ernst& Young LLP

202420238,0537,057–648,0537,12110-Q

?2024

201910312020

???

17.8%14A14A

????

12.5

?

2024

sotorasib (AMG 510)

AMG 51020232(i)2023112023831AMG 510(ii)AMG 510

14A.52

14A.53(1)14A.5214A.53(1)(a) 14A(b)(c)(d)

14A.5514A.56(e) 2019111

?2024

(a)

=50%x(b)?

(i)(ii)(iii)(x)

(y)20AMG

=x?

=x

?

2024

12.5

1,2503,750

(a)(b)(c)

14A.563000740

2024123120241231(a)(b)

(c)

2024123114A.71

?2024

20246520242016100%

37,72837,728200%75,4568,384

Olivier BrandicourtMargaret Han DuganDonald W.GlazerMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. Sanders1,257

1,236,989

2024416202461220244262024123114A.71

2,069,546

399.43137

2024123126

14A14A

?2024

Committee of Sponsoring Organizations of the Treadway Commission2013

?2024

?2024

????

(i)(ii)

?2024

20241231

D.2.3

Chan Lee202412313.29

6162

?2024

(Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand CaymanKY1-1108,Cayman IslandsAeschengraben 27, 21st Floor, 4051 Basel, Switzerland

(Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, CamanaBay, Grand Cayman KY1-1108, Cayman Islands[]

Aeschengraben 27, 21st Floor, 4051 Basel, Switzerland[]

www.beigene.com

(i)(ii)(iii)(iv)(v)(vi)

?2024

2024123120231231

2024228www.beigene.com

10-K

2025

202487

2024872025

?2024

264348

20241231

20241231

?

2024

20241231

1,00778%

?2024

?

2024

?

???

?2024

??

2025327

?

2024

123120242023

2,627,4103,171,800 6676,278358,027 7494,986416,122 12192,919257,465

3,991,5934,203,414 91,578,4231,324,154 8139,30995,207 1051,09557,138 12160,490125,362

1,929,3171,601,861

5,920,9105,805,275

13404,997315,111 12803,713693,731 1125,93022,951

17,57621,950 3111,15468,004 14851,529688,366

2,214,8991,810,113

?2024

123120242023

14166,484197,618 844,27722,251 1142,00716,494 354,286170,662 1266,73550,810

373,789457,8352,588,6882,267,948

0.00019,500,000,000 2024123120231231 1,387,367,7041,359,513,224138135 12,087,90811,598,688 19(148,988)(99,446) (8,606,836)(7,962,050)

3,332,2223,537,3275,920,9105,805,275

?

2024

123120242023

153,779,5462,189,852 330,695268,927

3,810,2412,458,779

594,089379,9203,216,1522,078,859 1,953,2951,778,594 1,831,0561,508,001 3,784,3513,286,595

(568,199)(1,207,736) 47,83674,009 5(12,638)307,891

(533,001)(825,836) 11111,78555,872

(644,786)(881,708)17(0.47)(0.65)171,368,746,7931,357,034,547ADS(6.12)(8.45)

ADS105,288,215104,387,273

?2024

123120242023(644,786)(881,708) 19(47,565)(25,464) 22(1,942)(5,611) 19(35)9,046

(694,328)(903,737)

?2024

123120242023

(644,786)(881,708) 171,76287,675 18441,618367,618 360,00046,800 3(73,226)(55,294) 524,02216,221 25,983689 (BMS)–(362,917) 11,163(5,998) (329,443)(188,306) (91,496)(140,948) 45,12612,120 121,49721,484 111,354180,111 633(255,587) (14,838)587

(140,631)(1,157,453) (492,663)(561,896) 2,655673,240 (31,800)(15,000) 10(4,674)(19,365) 5(19,006)(14,900) (2,862)(2,075)

(548,350)60,004

?2024

123120242023 149,05322,502 14(28,031)(13,690) 14868,270661,530 14(704,216)(309,576) 45,37355,712 3,000–

193,449416,478(51,705)(8,082)(547,237)(689,053)3,185,9843,875,0372,638,7473,185,984 2,627,4103,171,800 9,31211,473 2,0252,711 69,43056,003 51,17519,753 70,31491,804 60,00031,800

?2024

202212311,356,140,18013511,540,979(77,417)(7,080,342)4,383,355

84,227–––––26,561,925253,006––53,008(23,273,108)(2)(362,915)––(362,917)

––367,618––367,618–––(22,029)–(22,029)––––(881,708)(881,708)202312311,359,513,22413511,598,688(99,446)(7,962,050)3,537,327

(2,258,161)–––––30,112,641345,550––45,553

––2,052––2,052––441,618––441,618–––(49,542)–(49,542)––––(644,786)(644,786)202412311,387,367,70413812,087,908(148,988)(8,606,836)3,332,222

?2024

1.202438

201011,00020241231

*2,722,787,023100%

*15,913,108,600100%*1,434,344,310100%*4,273,218,389100%*620,000,000100%BeiGene USA, Inc.1100%BeiGene AUS Pty Ltd56,947,230100%BeiGene Switzerland GmbH

20,000100%BeiGene Hopewell Urban Renewal, LLC683,693,128100%*

?

2024

2.

?2024

2.

?

2024

2.

?2024

2.

?

??

?

?

?2024

2.

20241231202312317,635,0007,529,000

842842

842-20-2520241231

?2024

2.

20241231

?2024

2.

202420231231

202420231231

?2024

2.

820820

820(1)(2)(3)

?2024

2.

202420231231

20241231

950,704–– ––618 2,113168– ––4,616

952,8171685,234

20231231

1,052,149–– 2,600–– ––4,668 3,046542– ––4,215

1,057,7955428,883

?

2024

2.

Leap Therapeutics, Inc.LeapLeap

1Leap

2024202312314,842,0001,492,000202420231231202420231231042,852,000

202420231231

?2024

2.

606606

(i)(ii)(iii)

(iv)(v)

?????

EUSA Pharma

100%

?2024

2.

3090

NRDL

?2024

2.

606808

?2024

2.

(i)(ii)

?2024

2.

(i)(ii)(iii)(iv)

(v)

?2024

2.

20242023123122,326,00023,989,000

20242023123130,235,00034,084,0002024202312313,053,0002,938,00020242023123189,000120,000202420231231

?2024

2.

718718

718505505-50

?2024

2.

50%

?2024

2.

PSUPSU

?2024

2.

2024202312312,627,410,0003,171,800,000

202420231231676,278,000358,027,000

20241231ASD Specialty HealthcareMcKesson

18.0%16.9%11.1%20241231

51.0%

20231231ASD SpecialtyHealthcare16.0%14.2%12.4%11.4%2023123153.2%20231231

?2024

2.

202311(FASB)(ASU)2023-07280

2023121520241215

20241231ASU 2023-0727

202411FASBASU 2024-03220-40

(1)(2)

(3)(4)20251FASBASU 2024-03

220-40ASU 2024-032026121520271215202312FASBASU 2023-09740

(1)(2)

5%(3)20241215

?2024

3.

20241231

2024202420231231

123120242023–79,431–104,477–71,98030,69513,03930,695268,927

?

2024

3.

20211

650,000,00020239

20239

?2024

3.

202420231231

123120242023

–72,278

2,1135,0672,11377,345

202112

TIGIT

?????

2022

300,000,00020237

?2024

3.

202420231231

123120242023

–7,153–104,477–71,980

18,2598,85918,259192,469

201910

???202012

???

?2024

3.

1,250,000,000KRAS G12CLUMAKRAS (sotorasib)AMG 510AMG 5102022420

LUMAKRAS20232(i)2023112023831

LUMAKRAS(ii)LUMAKRAS

808100%

?2024

3.

20191031202012174.8515,895,001

20.5%

Anthony Hooper2020120231

132.74

2,109,902,000601,857,000

2,779,241,0002,162,407,000616,834,000

?2024

3.

202420231231

123120242023148,391108,60873,22655,29475,16553,314

20241231335,261202420231231

123120242023111,15468,004

54,286170,662165,440238,666

?

2024

3.

20241231

12312024202337,1508,358(83,674)(60,917)(2,438)1,688(48,962)(50,871)

202420231231247,655,000108,691,000202420231231116,563,00055,474,000

?2024

3.

202420231231

12312024202360,02746,80054,000––24,365114,02771,165

202420231231

?2024

4.

202420231231

1231202420239,31211,4732,0252,71111,33714,184

20241231588,235,000

?2024

5.

123120242023

Leap2,1133,046 Leap168542 Pi Health, Inc.

40,798– 48,15755,860

33,08125,981124,31785,429

Leap

2024Pi Health38,063,000

Pi Health, Inc.40,798,0001,000,000202412313,735,000Pi Health

123120242023(1,307)(425)(7,596)(6,448)(10,275)(7,856)

?2024

6.

123120242023677,270360,053

(992)(2,026)

676,278358,02730120

1231202420236674,633356,2436121,6451,784

676,278358,027

123120242023112,026211

(1,034)1,861

(1)(43)

1(3)12319922,026

?2024

7.

123120242023170,584148,772

60,11839,098264,284228,252494,986416,122

8.

123120242023

26,57525,978

4,5806,1012,8971,683

34,05233,762

?

2024

8.

12312024202360,63943,49078,67051,717139,30995,207

17,57621,95044,27722,25161,85344,201

2025123119,8242026123113,2792027123112,5832028123111,738202912317,188

3,92268,534(6,681)61,853

?2024

8.

12312024202356,00527,98547,06611,854

123120242023

5.23%7.22%

9.

12312024202365,48565,485607,857231,656244,255186,856240,885205,349100,34883,28164,68060,1241,323,510832,751

(399,105)(249,212)

654,018740,6151,578,4231,324,154

?2024

9.

20241231272,670,00020241231

500,900,00020252024373,054,00029,431,00043,623,0002024522,538,0002024202312312024

123120242023528,629579,64989,897119,3809,80516,13525,68725,451654,018740,615202420231231166,938,00080,436,0002024123159,792,000

?2024

10.

202420231231

2024123120231231

62,889(12,370)50,51964,274(7,807)56,4678,987(8,411)5768,987(8,316)67171,876(20,781)51,09573,261(16,123)57,138

1231202420234,7293,739953,5004,8247,239

?

2024

10.

20241231

123120254,682674,74920264,682674,74920274,682674,74920284,682674,74920294,682674,749203027,10924127,350

50,51957651,095

11.

123120242023201,516117,446(263,159)(315,852)(471,358)(627,430)(533,001)(825,836)

?2024

11.

123120242023

57,22225,17012,33124,95616,2255,05985,77855,18523,556–

1806872,271–26,007687111,78555,872

?2024

11.

123120242023(533,001)(825,836)21%21%(111,930)(173,426)93,741144,310

1,13019,13453,44632,581(7,988)(5,872)157,286845,811

–(704,928)(43,602)(64,343)(13,644)–

23,743–(40,397)(37,395)111,78555,872(21.0)%(6.8)%

?2024

11.

123120242023121,549106,7081,137,890996,58838,39726,68734,56168,117704,928704,9281,081,442699,97411,8827,893277,061164,1903,407,7102,775,085(3,403,505)(2,771,470)4,2053,615(10,795)(12,374)(23,735)–(11,682)(7,735)(46,212)(20,109)(42,007)(16,494)20241231

?

2024

11.

202420231231

123120242023112,771,4701,943,775

157,286845,811497,823–(23,074)(18,116)12313,403,5052,771,4702024202312316,720,659,0005,945,753,000

20241231202520342,185,546,000202520314,526,020,00043,677,00020362044704,928,000

2028202420231231

1231202420231114,26411,555

2,9752,709123117,23914,264

2024123117,239,00012

?2024

11.

202420231231

202412312013202420142024

2021202420152024

201420242025202412314,631,000

0.01

2024

23,735,00012.

12312024202364,27760,47623,79237,32032,82837,85921,25314,61919,33342,0669,31211,4736,2428,87215,88244,780192,919257,465

?2024

12.

123120242023128,93389,644

12,24918,122

8,4818,1955,9274,1442,8752,5462,0252,711160,490125,362

123120242023248,348217,803235,600139,936154,269162,96977,53087,57231,10636,20334,90430,08321,95619,165803,713693,731

?2024

12.

12312024202330,32434,20416,40514,9953,7941,12716,21248466,73550,810

13.

202420231231

1231202420233401,252302,310368718,205612,6154,551125945

404,997315,111

?

2024

14.

202420231231

123120242023

580,000

92027611116,440120,00014,089100,000350,000

9202912028,61162,8578,85662,857378,000

9202911838,14859,4755,63640,000 480,000

10203272841,38410,100––380,00015380,0002,773,723300,0002,129,321150,0001202512166.8%150,0001,094,891150,0001,064,660675,000

3642025327692,475675,000––400,000

12025653.0%54,800400,00056,356400,000340,000

1202555746,580340,00047,903340,000 200,000

120245292.8%––28,177200,000700,000

1202511242.9%93,091679,49249,312350,000 200,000

120245243.2%––28,037199,000

851,5296,215,538688,3664,885,838580,000

92027611141,100300,00059,174420,000350,000

92029120227,987204,28637,638267,143378,000

92029118333,020241,02542,337300,500 480,000

102032728464,377469,90058,469415,000

166,4841,215,211197,6181,402,643

?2024

14.

1. 20241231

4.2%2024123113,739,000100,000,000

2. 20241231

3.7%202412318,730,00062,857,000

3. 20241231

3.8%202412315,562,00040,000,000

4. 20241231

3.7%202412319,053,00065,000,000

5. (SOFR)20241231

6.2%80,000,0002025127300,000,00020251217

6. 20241231

2.6%

7. 202412314.4%

20241231

?2024

14.

20241231

20251231851,5292026123146,2072027123146,2072028123125,6572029123119,657

28,7561,018,013

20242023123146,894,00020,800,00032,158,00016,571,00020242023123119,723,0003,484,00015.

???????

?202420231231

1231202420234,786,7442,718,969(1,007,198)(529,117)3,779,5462,189,852

?2024

15.

202420231231

123120242023

?

2,644,2261,290,396?

620,836536,620

?

224,40392,828

?

74,33154,342?

66,17139,799?

53,50956,547?

36,02876,018

60,04243,3023,779,5462,189,852202420231231

2022123141,8178,58050,397 275,031254,086529,117 (176,912)(232,231)(409,143)20231231139,93630,435170,371 491,756515,4421,007,198 (396,092)(495,178)(891,270)20241231235,60050,699286,299

?2024

16.

123120242023594,089379,9209166,93880,436

1,953,2951,778,594826,57525,978104,8247,239

8,0537,121 1,305,1471,120,403 18441,793367,588 74,09862,092

1,821,0381,550,083

15,98664,7606(1,034)1,861

4,0662,964(69,641)(78,373)

202420231231779,306,000699,289,000

?2024

17.

123120242023 (644,786)(881,708) 1,368,746,7931,357,034,547

(0.47)(0.65)202420231231

202420231231

?2024

18.

2016201612016

20162016265,029,5952016

201120112016

201120241231201120165,166,9002016201711

(i)(5%)(ii)

20181129,603,6162016201882016201812201638,553,159202062016

57,200,0002030413201620241231201683,064,175

20162016

201666,300,00020223315%202262220246201692,820,000

?2024

18.2018201862018201812,000,000

5635(c)(4)5635(c)(4)20182018

201620188

201820162018202262220182018620183,500,000

201882018123,855,3157,355,315202465,070,00012,425,3156

15%10%

?2024

18.

2018

20248311,035,996165.2012.69140.2710.7811,17820242291,021,397165.6512.74140.8010.8311,0632023831794,144207.5515.97176.4213.5710,7772023228930,582171.1013.16145.4411.1910,4142022831861,315171.6613.20145.9111.229,6672022228667,160210.5216.19178.9413.769,183

202412314,953,682

?2024

18.

201120162018

2022123176,526,8537.85 9,817,92516.378.14 (6,974,331)4.5492,051 (1,225,334)17.60

2023123178,145,1139.06 9,180,30112.536.62 (6,812,624)3.8769,946 (2,530,134)15.87

2024123177,982,6569.704.83429,581

2024123160,173,2808.423.7406,868

2024123175,311,2509.554.7426,174

2024123115,137,97082,424,000

2.4

?2024

18.

20242023123168,420,00061,121,000

123120242023

5.72~9.197.26~10.72

3.8% ~ 4.6%3.4% ~ 4.6%

2.82.857% ~ 58%58% ~ 60%

0%0%1010

?

2024

18.

20162018

2022123155,397,17314.87 34,573,99415.57 (17,862,598)14.71 (5,707,546)15.47

2023123166,401,02315.22 49,693,59212.53 (21,251,477)15.53 (9,012,471)14.46

2024123185,830,66713.67

2024123172,956,06713.67

20241231801,403,000

2.7

202420231231

123120242023186,113163,550255,680204,038441,793367,588

?2024

19.

20221231(62,523)(9,011)(5,883)(77,417)

(25,464)9,046(6,422)(22,840)

––811811(25,464)9,046(5,611)(22,029)

20231231(87,987)35(11,494)(99,446)

(47,565)(35)(2,753)(50,353)

––811811(47,565)(35)(1,942)(49,542)20241231(135,552)–(13,436)(148,988)

?

2024

20.

202420231231BMS202381BMS-Celgene

ABRAXANE

?20172018BMS-Celgene

201723,273,10820231231

??20252

2023815362,917,000

20231231

21.

?2024

21.

10%50%

202420231231

10%

2024202312311,709,961,0002,114,277,00022.

202420231231101,779,00094,358,000401(k)401(k)401(k)

401(k)20246%202420231231

401(k)20,839,00015,316,000

?2024

22.

2024202312313,825,0002,710,000

20242023123180,199,00070,600,00063,794,00055,605,00020253,922,000

1020241231

20251231692202612316042027123199420281231593202912311,922

8,65713,462

?2024

23.

20241231131,944,00032,538,000

99,406,000

2024123148,347,000

1,250,000,00020241231335,261,000

15,053,000202412317,404,000

(CRO)

?2024

24.

383(1)(a)(b)(c)(f)2202420231231

123120242023888856 1,2971,275 1,5401,132 *19,54817,981

22,38520,38823,27321,244* 2425

202420231231

?

2024

24.

(a)

20242023123120241231

Olivier Brandicourt

85––354–439Shalini Sharp

21––88–109Donald W. Glazer

69––614–683Michael Goller85––410–495Anthony C. Hooper130––410–540Ranjeev Krishana90––410–500Thomas Malley

5––14–19Corazon (Corsee)

D. Sanders103––410–513

90––410–500Margaret Han Dugan115––410–525Alessandro Riva95––410–505

888––3,940–4,828

1.

Olivier Brandicourt2024123

2.

Shalini Sharp2024927

3. Donald W. Glazer20241025

4.

Thomas Malley2024122

?2024

24.(a)

20231231

Thomas Malley101––405–506Donald W. Glazer81––405–486Michael Goller82––405–487Ranjeev Krishana87––405–492

87––405–492Corazon (Corsee)

D. Sanders102––405–507Alessandro Riva92––405–497Margaret Han Dugan111––405–516Anthony C. Hooper

113––405–518856––3,645–4,501

1.

Anthony C. Hooper20234172023416

Anthony C. Hooper2023416Anthony C. Hooper

?2024

24.(b)

202420231231

202420231231

123120242023–– 1,2971,275 1,5401,132 15,61014,336

18,44716,743202420231231

202420231231

20241231

100–1503,948–4,198

?2024

24.(b)

20231231

267–1503,854–4,271

25.

202420231231

20242023

123120242023

3,6012,2231,3441,64420,26718,874

211725,23322,758

?2024

25.

2024202335,000,00140,000,000–150,000,00155,000,0001160,000,00165,000,0001–80,000,00185,000,0001–90,000,00195,000,000–1

202420231231

26.

202420231231(a) 20241231

(i)100,0002023100,000(ii)150,0002023150,000(iii)410,6572023327,2492,667,00020232,667,000(iv) 108,992202386,216

1,333,00020231,333,000(v)20231231

(HSR)167,000(b)

12312024202310,2348,120513342,57538,15752,86046,31014A

?2024

27.

1231202420231,957,4981,128,2191,950,530945,5516,968182,6681,411,3071,101,9511,390,6991,093,09120,6088,860362,626202,014359,507122,2283,11979,78678,81026,59578,81028,982–(2,387)3,810,2412,458,779

?

2024

28.

20241231

(i)(iii)(1,953,295)(21,357)1,338(1,973,314)(1,831,056)(17,535)1,814(1,846,777)47,836–(2,677)45,159(533,001)(38,892)475(571,418)(111,785)(1,954)–(113,739)(644,786)(40,846)475(685,157)

20231231

(i)(iii)(1,778,594)(31,745)1,344(1,808,995)(1,508,001)(21,942)1,659(1,528,284)

74,009–(3,082)70,927(825,836)(53,687)(79)(879,602)

(55,872)(15,000)–(70,872)(881,708)(68,687)(79)(950,474)

?

2024

28.

20241231

(i)(ii)(iii)139,309––(1,909)137,4005,920,910––(1,909)5,919,00112,087,90840,846––12,713,377

276,729*307,894*–(8,606,836)(40,846)–475(9,234,214)

(276,729)*(307,894)*(2,384)*3,332,222––(1,909)3,330,313

20231231

(i)(ii)(iii)95,207––(2,384)92,8235,805,275––(2,384)5,802,89111,598,68868,687––12,183,311

208,042*307,894*–(7,962,050)(68,687)–(79)(8,549,057)

(208,042)*(307,894)*(2,305)*3,537,327––(2,384)3,534,943

*

?

2024

28.

(i)

2024123138,892,000202353,687,000

(ii)

20162307,894,000

307,894,000

?2024

28.

(iii)

?2024

29.

123120242023

400,135723,964 249,016785,471

649,1511,509,435 1,731,2662,030,249 2,081,3351,207,352 114,72869,361

4,576,4804,816,397

424,111197,289 –362,917 762,146547,215

1,186,2571,107,421 58,000171,649

1,244,2571,279,070

3,332,2233,537,327

4,576,4804,816,397

?2024

29.

202212311,356,140,18013511,540,979(77,417)(7,080,342)4,383,355

84,227––––– 26,561,925253,006––53,008

(23,273,108)(2)(362,915)––(362,917)

––367,618––367,618–––(22,029)–(22,029)––––(881,708)(881,708)

202312311,359,513,22413511,598,688(99,446)(7,962,050)3,537,327

(2,258,161)––––– 30,112,641345,550––45,553

––2,052––2,052––441,618––441,618–––(49,542)–(49,542)––––(644,786)(644,786)202412311,387,367,70413812,087,908(148,988)(8,606,836)3,332,222

?2024

30.

2024123120231231

31.

2025327

?2024

2011201141520154172011201620181272016

20224

201820182021616

202191

ADS

20162024652016

20244

2018

2024652018

20244

198747

20191031202012

20191031

?2024

2023615

20101028

2017125201733BeiGene Switzerland GmbH201791BLABMSBMS-CelgeneCelgene Switzerland LLC

Celgene Kappa Holdings LLCCelgene Holdings EastCorporation

CMO

?2024

C1 CRO

(i)(ii)(iii)

Ernst & Young AG

EMA(European Medicines Agency)

FDA(U.S. Food and Drug Administration)

(General Data Protection Regulation)(EU)2016/679

?

2024

GEMC3

NMPA(National Medical Products Administration)

Novartis Pharma AG NRDL

?2024

2018730

201620241231

20162016

sNDA

?2024

GAAPGAAP

?2024

ADCBRAFB-raf BTK

BcHLCLL

FcγFcγFL

MCLMZLNMENSCLC

?2024

PARPADP

DNADNAPD-11Tpro-B

PD-L1PD-L2PD-1T

SLLTTT

BUCWM


  附件:公告原文
返回页顶